The NDC uniquely identifies a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.
The following 45 manufacturer / drug / strength / packaging combinations (NDCs) were added to one or more Medicare Part D formularies in the recent updates. You can click on the NDC or Drug Name below to go to our on this site DrugFinder to see the details of how this drug is handled by all Medicare Part D Plans in Florida -- You can then change the state to your state for details in your service area.
What Could the Addition of New Generic Drugs Mean to You?
- You may be able to save money by switching from the brand-name drug to its generic equivalent – with your prescriber’s approval and a new prescription. Please note, you will need to look carefully at coverage costs as we have found that many 2016 generics are being offered on the same tier as their brand-name equivalent or the generics do not have a significantly lower retail price. For example, the brand-name Targretin (75 mg) may have a retail cost of around $7,464 as a Tier 5 drug (30% co-insurance) and the same plan may now cover the generic equivalent BEXAROTENE 75 MG also as a Tier 5 drug (30% co-insurance) with a retail price of around $6,607. You can click here to see how your Medicare drug plan is covering these medication.
- Your brand name drug may no longer be available if a generic is now available. From past experience, we expect to find that many Medicare Part D plans may discontinue coverage of brand-name drugs over the next few months when generic drug equivalents are introduced. For example, the brand-name drug PrandiMet has already been removed from all 2016 Medicare Part D formularies and replaced with the generic REPAGLINIDE-METFORMIN. If you have received notice from your Medicare Part D plan that your brand-name medication will be dropped, you should speak with your prescriber to determine if you can take the generic equivalent or if you will need to ask your plan for a formulary exception to continue coverage for the brand-name drug. You can click for a chart showing the trends in formulary coverage for some of the most popular Medicare drugs and their generic equivalents.